Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
634studies shown
Showing 457-468 of 634
Other study type icon
TerminatedNCT04708834

Long-term Safety Study of Adjunctive Troriluzole in Subjects With OCD

This study has public registry information. It focuses on OCD and currently lists study information in Canada, Italy, the Netherlands, Spain, the United Kingdom, and the United States.

In Canada
OCDOtherFrom 18 Years to 65 Years
Countries
United States, Canada, United Kingdom, ...
Sponsor
Biohaven Pharmaceuticals, Inc.
Condition
OCD
Drug study icon
CompletedNCT00868959

Lurasidone - A 24-week Extension Study of people with Bipolar I Depression

This study is completed. It focuses on bipolarity and currently lists study information in Canada, Colombia, Czech Republic, France, India, Japan, Lithuania, Peru, Poland, Romania, Russian Federation, Slovakia, South Africa, Ukraine, and the United States.

In Canada
Bipolarity, DepressionOtherFrom 18 Years to 75 Years
Countries
United States, France, Canada, ...
Sponsor
Sumitomo Pharma America, Inc.
Condition
Bipolarity, Depression
Drug study icon
CompletedNCT02147379

Lurasidone and Cognition in Bipolarity type I

This study is completed. It focuses on bipolarity and currently lists study information in Canada.

In Canada
BipolarityOtherFrom 19 Years to 65 Years
Countries
Canada
Sponsor
University of British Columbia
Condition
Bipolarity
Drug study icon
CompletedNCT01485640

Lurasidone Extended Use Study

This study is completed. It focuses on schizophrenia and currently lists study information in Canada, Colombia, Czech Republic, France, India, Lithuania, Romania, Russian Federation, Serbia, Slovakia, South Africa, and Ukraine.

In Canada
Schizophrenia, BipolarityOther
Countries
France, Canada, Colombia, ...
Sponsor
Sumitomo Pharma America, Inc.
Condition
Schizophrenia, Bipolarity
Other study type icon
Enrolling By InvitationNCT06978881

Magnetoencephalography in Psychosis Program

This study is enrolling by invitation. It focuses on schizophrenia and currently lists participation information in Canada.

In Canada
SchizophreniaOtherFrom 18 Years to 50 Years
Countries
Canada
Sponsor
Douglas Mental Health University Institute
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.